| Literature DB >> 25649497 |
Nastaran Eizadi-Mood1, Shahla Akouchekian2, Ahmad Yaraghi3, Mehrnazsadat Hakamian4, Rasool Soltani5, Ali Mohammad Sabzghabaee1.
Abstract
Background. Psychiatric consultation is necessary for all patients with intentional poisoning and its reliability depends on the proper function of patients' memory performance. This study aimed to determine the possible memory impairment following acute TCAs' poisoning. Materials and Methods. In this cross-sectional study, patients with acute TCAs poisoning were allocated to two groups of severe poisoning (with coma, seizures, cardiac arrhythmias, hypotension, and a wide QRS complex) and mild-to-moderate poisoning according to their clinical presentation at the time of hospital admission. All patients underwent memory performance test both immediately and 24 hours after their initial consciousness after admission, using Wechsler Memory Scale (WMS-IV). Results. During the study period, 67 TCA-poisoned patients (aged, 20-64 years) were evaluated, of which 67.2% were female. The mean memory scores of patients immediately and 24 hours after the initial consciousness were 31.43 ± 9.02 and 50.62 ± 9.12, respectively (P < 0.001). Twenty-four hours after the initial consciousness, memory score was statistically correlated with the amount of ingested drug and the intoxication severity. Conclusion. Following the recovery from somatic symptoms of acute TCA poisoning, patients may still suffer from memory impairment and it seems that this time is not suitable for performing a reliable psychiatric consultation.Entities:
Year: 2015 PMID: 25649497 PMCID: PMC4310445 DOI: 10.1155/2015/835786
Source DB: PubMed Journal: Depress Res Treat ISSN: 2090-1321
Memory score of TCA-poisoned patients in terms of different parameters at the time of initial consciousness† and 24 hours afterward (mean ± SD) (n = 67).
| Parameter | Category |
| Initial consciousness | 24 hours after consciousness | ||
|---|---|---|---|---|---|---|
| Memory score |
| Memory score |
| |||
| Gender | Male | 22 | 29.97 ± 9.40 | 0.36* | 49.79 ± 9.89 | 0.60* |
| Female | 45 | 32.14 ± 8.83 | 51.03 ± 8.78 | |||
|
| ||||||
| Age range | 20–24 yrs | 45 | 32.80 ± 8.50 | 0.11** | 52.48 ± 8.90 | 0.002** |
| 25–34 yrs | 14 | 30.32 ± 9.60 | 47.85 ± 8.10 | |||
| 35–44 yrs | 5 | 26.90 ± 6.0 | 47.50 ± 2.10 | |||
| 45–54 yrs | 2 | 30.75 ± 8.83 | 49.0 ± 8.40 | |||
| 55–64 yrs | 1 | 9.0 ± 0.0 | 24.50 ± 0.0 | |||
|
| ||||||
| Severity | Mild-to-moderate | 52 | 32.31 ± 8.94 | 0.13*** | 46.30 ± 8.50 | 0.03*** |
| Severe | 15 | 28.36 ± 8.93 | 51.85 ± 8.90 | |||
|
| ||||||
| Dosage range | 100–500 mg | 42 | 34.71 ± 7.40 | <0.001** | 53.48 ± 8.10 | <0.001** |
| 501–1000 mg | 7 | 34.37 ± 8.50 | 53.62 ± 8.50 | |||
| >1000 mg | 18 | 21.94 ± 5.80 | 42.10 ± 6.10 | |||
|
| ||||||
| Total | 67 | 31.43 ± 9.02 | 50.62 ± 9.12 | <0.001**** | ||
†When the patients were awake and were able to communicate after admission.
*Independent samples t-test; **Pearson correlation test; ***Spearman correlation test; ****paired-samples t-test.